Lumito AB (NGM:LUMITO) Days Payable : 0.00 (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Lumito AB Days Payable?

Lumito AB's average Accounts Payable for the three months ended in Sep. 2024 was kr1.74 Mil. Lumito AB's Cost of Goods Sold for the three months ended in Sep. 2024 was kr-0.58 Mil.

The historical rank and industry rank for Lumito AB's Days Payable or its related term are showing as below:

NGM:LUMITO's Days Payable is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 61.87
* Ranked among companies with meaningful Days Payable only.

Lumito AB's Days Payable stayed the same from Sep. 2023 (0.00) to Sep. 2024 (0.00). stayed the same

Lumito AB Days Payable Historical Data

The historical data trend for Lumito AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumito AB Days Payable Chart

Lumito AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

Lumito AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Lumito AB's Days Payable

For the Diagnostics & Research subindustry, Lumito AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lumito AB's Days Payable Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lumito AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Lumito AB's Days Payable falls into.

Lumito AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Lumito AB's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (1.98	+	3.438)	/	2 )	/	-13.933	*	365
=	2.709					/	-13.933	*	365
=	N/A

Lumito AB's Days Payable for the quarter that ended in Sep. 2024 is calculated as:

	Days Payable (Q: Sep. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Sep. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
=	( (1.664	+	1.813)	/	2 )	/	-0.575	*	365 / 4
=	1.7385					/	-0.575	*	365 / 4
=	N/A

Lumito AB Days Payable Related Terms

Thank you for viewing the detailed overview of Lumito AB's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Lumito AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lumito AB (NGM:LUMITO) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Magistratsvagen 10, Lund, SWE, SE-226 43

Website

http://www.lumito.se

Lumito AB is a Swedish company that specializes in the medical research and development of imaging technology for use in digital pathology. It has developed a development and business plan for the development of an instrument for digital pathology that improves the quality of tissue sample mapping.

Lumito AB Headlines

No Headlines